Highlights From Innate Pharma (IPH.PA )'s R&D Update Today In New York
4/10/2014 7:42:56 AM
MARSEILLE, France, April 10, 2014 (GLOBE NEWSWIRE) -- Innate Pharma SA (the "Company" - Euronext Paris: FR0010331421 - IPH), the innate immunity company developing first-in-class drug candidates for cancer and inflammatory diseases, today holds an R&D update.
Help employers find you! Check out all the jobs and post your resume.
comments powered by